切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (04) : 467 -470. doi: 10.3877/cma.j.issn.1674-3946.2025.04.030.

综述

血清肿瘤标志物对结直肠癌患者术后复发的预测效能研究进展
赵晨皓1, 张序东1, 杨浚沫1, 周何1,()   
  1. 1. 637000 四川南充,川北医学院附属医院胃肠外科
  • 收稿日期:2025-03-20 出版日期:2025-08-26
  • 通信作者: 周何
  • 基金资助:
    2021年第一批四川省级科技计划立项项目(2021YJ 0456)

Research progress on the predictive efficacy of serum tumor markers for postoperative recurrence in patients with colorectal cancer

Chenhao Zhao1, Xudong Zhang1, Junmo Yang1, He Zhou1,()   

  1. 1. Department of Gastrointestinal Surgery, Affiliated Hospital of Sichuan North Medical College, Nanchong Sichuan Province 637000, China
  • Received:2025-03-20 Published:2025-08-26
  • Corresponding author: He Zhou
引用本文:

赵晨皓, 张序东, 杨浚沫, 周何. 血清肿瘤标志物对结直肠癌患者术后复发的预测效能研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 467-470.

Chenhao Zhao, Xudong Zhang, Junmo Yang, He Zhou. Research progress on the predictive efficacy of serum tumor markers for postoperative recurrence in patients with colorectal cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(04): 467-470.

血清肿瘤标志物在结直肠癌(CRC)的早期诊断、疗效评估及预后判断中已展现出一定价值,但在预测患者术后远期复发方面的效能仍需深入探索。CRC术后复发是一个复杂的多因素过程,其机制主要涉及癌细胞的隐匿性转移与增殖、肿瘤微环境的改变以及免疫逃逸等,风险因素包括患者年龄、家族史、病理分化程度、手术方式、辅助治疗的有效性以及生活习惯等。癌胚抗原(CEA)、糖类抗原19-9(CA19-9)等常用血清肿瘤标志物虽与CRC的病理特征存在显著相关性,在术后复发预测中具有一定作用,但面临手术应激反应、敏感性、特异性限制等挑战。未来发展方向包括深度整合血清标志物、影像学和基因组学等多模态数据,利用人工智能和机器学习技术构建和优化预测模型,以及加强跨学科合作,为患者提供更全面有效的预后评估及诊治策略。

Serum tumor markers have shown certain value in the early diagnosis, efficacy evaluation,and prognosis assessment of colorectal cancer (CRC). However, their effectiveness in predicting the long-term postoperative recurrence of patients still needs to be explored in depth. Postoperative recurrence of CRC is a complex multi-factorial process, and its mechanisms mainly involve the occult metastasis and proliferation of cancer cells, changes in the tumor microenvironment, and immune escape. Risk factors include the patient's age, family history, degree of pathological differentiation, surgical approach, effectiveness of adjuvant therapy,and lifestyle habits, etc. Although commonly used serum tumor markers such as carcinoembryonic antigen (CEA)and carbohydrate antigen 19-9 (CA19-9) have a significant correlation with the pathological characteristics of CRC and play a certain role in predicting postoperative recurrence, they face challenges such as surgical stress response and limitations in sensitivity and specificity. Future development directions include the in-depth integration of multimodal data such as serum markers, imaging, and genomics, the use of artificial intelligence and machine learning technologies to construct and optimize prediction models, as well as strengthening interdisciplinary cooperation to provide patients with more comprehensive and effective prognosis assessment,diagnosis, and treatment strategies.

[1]
顾晋. 腹腔镜直肠癌外科临床诊治中的问题与对策[J/CD].中华普外科手术学杂志(电子版),2022, 16(01): 9-12.
[2]
Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes[J]. Curr Drug Targets, 2021, 22(9): 998-1009.
[3]
Patel SG, Karlitz JJ, Yen T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology,clinical features, biology, risk factors, prevention, and early detection [J]. Lancet Gastroenterol Hepatol, 2022, 7(3): 262-274.
[4]
Song M, Liu Z, Wu F, et al. Serum tumor marker and CT body composition scoring system predicts outcomes in colorectal cancer surgical patients. Eur Radiol, 2024, 34(12): 7596-7608.
[5]
Abedizadeh R, Majidi F, Khorasani HR, et al. Colorectal cancer:a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments [J]. Cancer Metastasis Rev,2024, 43(2): 729-753.
[6]
徐一栋,俞甲子,张佳健,等. 结直肠癌肝转移瘤切除术后早期肝内复发相关因素分析和预测模型构建[J]. 癌症,2024,43(02): 76-87.
[7]
Hasselager RP, Hallas J, Gögenur I. Epidural Analgesia and Recurrence after Colorectal Cancer Surgery: A Danish Retrospective Registry-based Cohort Study [J]. Anesthesiology,2022, 136(3): 459-471.
[8]
Wu Y, Zhang S, Yan J. IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence [J]. Oncol Lett, 2020, 19(3): 1759-1770.
[9]
陈瀚玮,李磊. 结直肠癌肝转移肝切除术后不同复发模式的预后差异及危险因素分析[J/CD]. 肝癌电子杂志,2024,11(02): 27-32.
[10]
Försti A, Ambrozkiewicz F, Marciniak M, et al. Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers [J]. Int J Cancer, 2025,156(7): 1393-1403.
[11]
Suzuki Y, Ogura A, Uehara K, et al. The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer [J]. Int J Clin Oncol, 2021, 26(7): 1264-1271.
[12]
Pian G, Shin JS, Yoon S, et al. Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer [J]. Anticancer Res, 2021, 41(2): 1101-1110.
[13]
石彦科,颜廷启,孙伟涛,等. 血清CXCL12及其受体CXCR4、CXCR7与结肠癌患者临床病理特征及术后肝转移的关系研究[J]. 检验医学与临床,2025, 22(02): 178-183, 189.
[14]
魏丕喜,赵彩玲,唐思锋,等. 微小RNA-183、微小RNA-26a对结肠癌的诊断价值及与结肠癌预后的关系[J]. 中华实验外科杂志,2024, 41(09): 2074-2077.
[15]
张成熙,李启刚. 围术期CEA及CA19-9检测水平对结直肠癌术前分期及术后预后的影响[J]. 检验医学与临床,2018,15(24): 3698-3701, 3706.
[16]
Gao Y, Wang J, Zhou Y, Sheng S, et al. Evaluation of Serum CEA,CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer[J]. Sci Rep,2018, 8(1): 2732.
[17]
Huang H, Huang J, Huang W, et al. Clinical Observation and Analysis of Transient Postoperative CA-125 Elevation in a Patient with Sigmoid Colon Adenocarcinoma [J]. Clin Lab, 2025, 71(2):21-29.
[18]
朱磊,赵阳,韩仕峰,等. 术前血清CEA和CA19-9水平检测对结肠癌术后早期复发转移的预测价值[J]. 中国普通外科杂志,2015, 24(08): 1170-1174.
[19]
Han B, Hu H, Zhang J, et al. Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer [J].Br J Hosp Med (Lond), 2025, 86(2): 1-18.
[20]
曹鑫,丁杨青,徐玉凤,等. Ⅲ期结肠癌患者根治术后复发的影响因素分析[J]. 实用癌症杂志,2022, 37(11): 1820-1822.
[21]
Mizuno H, Miyake H, Nagai H,et al. Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/Ⅲ colon cancer [J]. Langenbecks Arch Surg, 2021, 406(6): 1987-1997.
[22]
Mazaki J, Tsukamoto S, Miyake M, et al. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy [J]. Dis Colon Rectum, 2021, 64(1): 71-80.
[23]
O'Brien SJ, Scheurlen K, Rochet A, et al. Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence [J]. J Surg Res, 2022, 269: 59-68.
[24]
Otani T, Kanemura H, Kimura M, et al. Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report [J]. Int J Surg Pathol,2022, 30(6): 646-651.
[1] 王浩瑜, 杨拴元, 任彦顺, 阴志强. 两种改良食管空肠吻合术的腹腔镜全胃切除术中临床对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 425-428.
[2] 林炳涛, 陈君填. 不同病理类型进展期胃癌患者临床特征及腹腔镜辅助根治术后短期预后的影响因素[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 429-433.
[3] 杨维军, 张文文, 付凯. 单切口腹腔镜下胃癌根治术治疗早中期胃癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 434-437.
[4] 袁强, 向文瑞, 吕远, 闫璋哲, 朱含放, 陈光, 孙亮, 陈纲, 赵锁. 基于随机生存森林的胃肠道间质瘤无复发生存期预测模型研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 438-441.
[5] 党立力, 张流, 周鹏, 周华友, 赵伟. 保留左结肠动脉(升支)腹腔镜直肠癌全系膜切除术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 442-445.
[6] 安霞, 石玉生, 宋智心. 结直肠癌早期筛查的实验室检测策略及临床价值分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 446-448.
[7] 曾舒昊, 康博禹, 郑高赞, 郑建勇, 丰帆. 青年结直肠癌患者的临床病理特征及预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 449-452.
[8] 王小贝, 吕庆福, 倪婷. 免充气腋窝入路与全乳晕入路腔镜下甲状腺癌根治术的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 368-371.
[9] 梁承友, 刘翼, 姚德炯, 朱明, 廖介. 三角入路在局部晚期直肠癌盆腔脏器联合切除术中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 392-395.
[10] 赵军抗, 张前进, 庄惠杰. 不同导向解剖入路腹腔镜根治术治疗早期直肠癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 401-404.
[11] 杨梦媛, 白启轩, 赵晓琳, 黄坤, 李珍, 曹世长, 程建平. ESD治疗腔内突出型结直肠肿瘤与大肠侧向发育型肿瘤的临床效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 405-408.
[12] 辛林璞, 杨敏, 杜峻峰. 五定四观察循证方案对直肠癌造口患者生活质量与应用效果的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 409-412.
[13] 王珂, 岳育民, 武珍珍, 许泽宇, 惠晓辉, 赵云, 窦维佳, 赵青川. 腹腔镜经自然腔道手术对结直肠癌患者肠道功能及远期效果的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 413-416.
[14] 詹文豪, 吾米尔·吾斯曼江, 刘仁, 曾小兰, 陈俊星, 王宗任. 经尿道膀胱肿瘤整块切除术与电切术治疗高危非肌层浸润性膀胱癌的比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(03): 309-314.
[15] 焦振东, 金上博. 腹腔镜肝癌切除术治疗肝癌破裂出血[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 641-641.
阅读次数
全文


摘要